Ellen Schlette

3.4k citations

69 papers · 2.3k indexed · h-index 28

Impact in

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment

Papers in ⓘ

Genetics 46
- Chronic Lymphocytic Leukemia Research 43
Pathology and Forensic Medicine 44
- Lymphoma Diagnosis and Treatment 44

Co-authors: L. Jeffrey Medeiros (39 shared papers)Michael J. Keating (22 shared papers)Raymond Lai (8 shared papers)George Z. Rassidakis (11 shared papers)William G. Wierda (16 shared papers)Susan O’Brien (7 shared papers)Alessandra Ferrajoli (12 shared papers)Francisco Vega (6 shared papers)
Journals: Blood (13 papers)Archives of Pathology & Laboratory Medicine (8 papers)American Journal of Clinical Pathology (8 papers)Cancer (4 papers)Human Pathology (4 papers)
Partner nations: United States Greece Australia

In The Last Decade

Ellen Schlette

67 papers receiving 2.3k citations

Peers

Countries citing papers authored by Ellen Schlette

Since Specialization

Citations

This map shows the geographic impact of Ellen Schlette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Schlette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Schlette more than expected).

Fields of papers citing papers by Ellen Schlette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Schlette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Schlette. The network helps show where Ellen Schlette may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen Schlette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Schlette Line = papers co-authored together Ellen Schlette links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia Blood ·Alessandra Ferrajoli, Bang-Ning Lee, Ellen Schlette, Susan O’Brien, Hui Gao, Sijin Wen, William G. Wierda, Zeev Estrov, Stefan Faderl, Evan N. Cohen, Changping Li, James M. Reuben, Michael J. Keating	2008	304
2	ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma Oncogene ·Rajesh R. Singh, Kranthi Kunkalla, Chuanxing Qu, Ellen Schlette, Sattva S. Neelapu, Felipe Samaniego, Francisco Vega	2011	139
3	Survivin Expression Predicts Poorer Prognosis in Anaplastic Large-Cell Lymphoma Journal of Clinical Oncology ·Ellen Schlette, L. Jeffrey Medeiros, André Goy, Raymond Lai, George Z. Rassidakis	2004	123
4	TCL1 shows a regulated expression pattern in chronic lymphocytic leukemia that correlates with molecular subtypes and proliferative state Leukemia ·Marco Herling, Kaushali A. Patel, Jahan S. Khalili, Ellen Schlette, Ryûji Kobayashi, L. Jeffrey Medeiros, Dan Jones	2005	110
5	Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia Blood ·Lorenzo Falchi, Michael J. Keating, Edith M. Marom, Mylene T. Truong, Ellen Schlette, Rachel L. Sargent, Long Trinh, Xuemei Wang, Susan Smith, Nitin Jain, Zeev Estrov, Susan O’Brien, William G. Wierda, Susan Lerner, Alessandra Ferrajoli	2014	97
6	Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia Journal of Clinical Oncology ·William G. Wierda, Susan O’Brien, Xuemei Wang, Stefan Faderl, Alessandra Ferrajoli, Kim‐Anh Do, Guillermo Garcia‐Manero, Jörge E. Cortes, Deborah A. Thomas, Charles Koller, Jan A. Burger, Susan Lerner, Ellen Schlette, Lynne V. Abruzzo, Hagop M. Kantarjian, Michael J. Keating	2011	96
7	Mantle Cell Lymphoma with 8q24 Chromosomal Abnormalities: a Report of 5 Cases with Blastoid Features Modern Pathology ·Suyang Hao, Warren G. Sanger, Mihaela Onciu, Raymond Lai, Ellen Schlette, L. Jeffrey Medeiros	2002	84
8	Outcomes in patients with splenic marginal zone lymphoma and marginal zone lymphoma treated with rituximab with or without chemotherapy or chemotherapy alone Cancer ·Apostolia M. Tsimberidou, Daniel Catovsky, Ellen Schlette, Susan O’Brien, William G. Wierda, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Sijin Wen, Kim‐Anh Do, Susan Lerner, Michael J. Keating	2006	84
9	mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3- mutated acute myeloid leukemia cells Molecular Cancer ·Weina Chen, Ηλίας Δράκος, Ioannis Grammatikakis, Ellen Schlette, Li Jiang, Vasiliki Leventaki, Efi Staikou-Drakopoulou, Efstratios Patsouris, Panayiotis Panayiotidis, L. Jeffrey Medeiros, George Z. Rassidakis	2010	80
10	Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens Blood ·Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O’Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Z. Rassenti, Stefan Faderl, Hagop M. Kantarjian, Lynne V. Abruzzo	2008	73
11	Mature B-Cell Leukemias With More Than 55% Prolymphocytes American Journal of Clinical Pathology ·Ellen Schlette, Carlos E. Bueso‐Ramos, Francis J. Giles, Armand B. Glassman, Kimberly Hayes, L. Jeffrey Medeiros	2001	66
12	Immunophenotypic Study of Basophils by Multiparameter Flow Cytometry Archives of Pathology & Laboratory Medicine ·Xiaohong Han, Jeffrey L. Jorgensen, Archana Brahmandam, Ellen Schlette, Yang O. Huh, Yuankai Shi, Sylvester Awagu, Weina Chen	2008	64
13	CD23 Expression in Mantle Cell Lymphoma: Clinicopathologic Features of 18 Cases American Journal of Clinical Pathology ·Ellen Schlette, Kai Fu, L. Jeffrey Medeiros	2003	58
14	Whole-Genome Scanning by Array Comparative Genomic Hybridization as a Clinical Tool for Risk Assessment in Chronic Lymphocytic Leukemia Journal of Molecular Diagnostics ·Shelly Gunn, M.H. Afif, M. Gorre, Philip D. Cotter, Jae‐Weon Kim, David W. Bahler, Sergey N. Preobrazhensky, Russell A. Higgins, Aswani R. Bolla, Sahar Ismail, Daphne de Jong, Eric Eldering, Marinus H. J. van Oers, Clemens Mellink, Michael J. Keating, Ellen Schlette, Lynne V. Abruzzo, Ryan S. Robetorye	2008	56
15	Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21) Leukemia ·Ηλίας Δράκος, Ruby Singh, George Z. Rassidakis, Ellen Schlette, J. Li, Francois X. Claret, R. Ford, Francisco Vega, L. Jeffrey Medeiros	2011	54
16	Rapid Response to Vemurafenib in a Heavily Pretreated Patient With Hairy Cell Leukemia and a BRAF Mutation Journal of Clinical Oncology ·Javier Muñoz, Ellen Schlette, Razelle Kurzrock	2013	53
17	Cytogenetic Findings in Mantle Cell Lymphoma American Journal of Clinical Pathology ·Mihaela Onciu, Ellen Schlette, L. Jeffrey Medeiros, Lynne V. Abruzzo, Michael J. Keating, Raymond Lai	2001	47
18	Expression of inhibitor of apoptosis proteins in B‐cell non‐Hodgkin and Hodgkin lymphomas Cancer ·Nalân Akyürek, Yongsheng Ren, Georgios Z. Rassidakis, Ellen Schlette, L. Jeffrey Medeiros	2006	45
19	MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis British Journal of Haematology ·Yang O. Huh, Katherine I‐Chun Lin, Francisco Vega, Ellen Schlette, C. Cameron Yin, Michael J. Keating, Rajyalakshmi Luthra, L. Jeffrey Medeiros, Lynne V. Abruzzo	2008	42
20	CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course Modern Pathology ·Zhihong Hu, Yi Sun, Ellen Schlette, Guilin Tang, Shaoying Li, Jie Xu, C. Cameron Yin, Ken H. Young, Keyur P. Patel, Roberto N. Miranda, Maitrayee Goswami, Michael Wang, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, Sa A. Wang	2017	39

About Ellen Schlette

Ellen Schlette is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Molecular Biology and Oncology, having authored 69 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (44 papers), Chronic Lymphocytic Leukemia Research (43 papers), Immunodeficiency and Autoimmune Disorders (14 papers), Viral-associated cancers and disorders (10 papers), Acute Myeloid Leukemia Research (8 papers), Chronic Myeloid Leukemia Treatments (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.3k citations), Hematology (412 citations), Immunology (632 citations) and Oncology (700 citations). Ellen Schlette has collaborated with scholars based in United States, Greece and Australia. Frequent co-authors include L. Jeffrey Medeiros, Michael J. Keating, Raymond Lai, George Z. Rassidakis, William G. Wierda, Susan O’Brien, Alessandra Ferrajoli, Francisco Vega, Lynne V. Abruzzo and Zeev Estrov. Their work appears in journals such as Blood, Archives of Pathology & Laboratory Medicine, American Journal of Clinical Pathology, Cancer and Human Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact